Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
Current experimental monoclonal antibodies (mAbs) for Ebola virus (EBOV) post-exposure immunotherapy are ineffective against Sudan (SUDV) or Marburg virus (MARV). Here, authors develop cocktails of mAbs that protect nonhuman primates against EBOV, SUDV, and MARV infection when given four days post i...
Saved in:
Main Authors: | Jennifer M. Brannan, Shihua He, Katie A. Howell, Laura I. Prugar, Wenjun Zhu, Hong Vu, Sergey Shulenin, Shweta Kailasan, Henna Raina, Gary Wong, Md Niaz Rahim, Logan Banadyga, Kevin Tierney, Xuelian Zhao, Yuxing Li, Frederick W. Holtsberg, John M. Dye, Xiangguo Qiu, M. Javad Aman |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/b99aa7a0e5ce4018ab41eac4e31287f3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
by: Logan Banadyga, et al.
Published: (2021) -
Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
by: Benjamin M. Janus, et al.
Published: (2018) -
Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time
by: Haiyan Wei, et al.
Published: (2017) -
Discovery of an ebolavirus-like filovirus in europe.
by: Ana Negredo, et al.
Published: (2011) -
Risks Posed by Reston, the Forgotten Ebolavirus
by: Diego Cantoni, et al.
Published: (2016)